Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Trilogy Metals Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Research and development
1.07
General and administrative
1.34
1.39
1.53
1.84
1.65
1.52
1.29
1.33
1.22
1.33
Operating expenses
8.92
18.9
21.9
28.4
12.2
8.62
6.93
Income tax
0
0
0
0
0
0
0
0
0
0
Income from continuing operations
-8.71
-21.1
-21.8
Net income
-4.86
-21.1
-21.8
-27.9
162
-21.7
-24.3
-15
-8.59
-42.2
EPS, basic
0.05
0.20
-0.18
-0.21
1.14
-0.15
-0.17
-0.10
-0.05
-0.26
EPS, diluted
0.05
0.20
-0.18
-0.21
1.12
-0.15
-0.17
-0.10
-0.05
-0.26
Shares, basic (weighted)
105
106
122
135
141
144
146
153
160
165
Shares, diluted (weighted)
105
106
122
135
145
144
146
153
160
165
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
7.34
5.39
23
19.2
11.1
6.31
2.57
2.59
25.8
51.6
Short-term investments
7.54
2.52
0
Receivables
0.05
0.47
0.02
0.26
0.13
0.02
0.02
0.03
0.02
0.12
Other current assets
0.72
0.72
0.62
0.72
0.18
0.29
0.32
0.26
0.2
0.19
Total current assets
15.6
9.1
23.6
20.2
11.4
6.61
2.91
2.88
26
51.9
Property, plant and equipment
0.22
0.48
0.33
0.72
0.21
0.03
0.01
0
Lease right-of-use assets
0.68
0.48
0.48
0.32
0.11
0.16
0.12
Long-term investments
0.3
0
Total assets
46.7
40.3
54.7
51.6
185
167
146
138
134
157
Accounts payable
0.16
2.77
0.4
0.9
0.23
0.21
0.19
0.15
0.2
0.65
Accrued liabilities
0.28
1.29
0.5
0.72
0.2
0.11
0.04
0.05
0.06
0.31
Total current liabilities
0.59
4.25
1.66
2.35
1.05
1.03
0.53
0.47
0.79
33.1
Lease liabilities
0.41
0.24
0.03
0.11
0.07
Total liabilities
0.59
14.6
22.5
33.4
1.45
1.27
0.57
0.47
0.9
33.2
Paid-in capital
18.1
18.4
19.1
21.1
23.3
26
27.4
28.2
28.8
27.3
Retained earnings
-112
-133
-155
-183
-20.9
-42.6
-66.9
-81.8
-90.4
-133
Shareholders' equity
46.2
25.7
32.2
18.3
184
166
145
138
133
124
Total equity
46.2
25.7
32.2
18.3
184
166
145
138
133
124
Total liabilities and equity
46.7
40.3
54.7
51.6
185
167
146
138
134
157
Shares outstanding
105
106
132
144
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-4.86
-21.1
-21.8
-27.9
162
-21.7
-24.3
-15
-8.59
-42.2
Depreciation and amortization
0.08
0.11
0.16
0.21
0.09
0.02
0.02
0.01
0
Stock-based compensation
0.62
-0.71
-1.44
-3.85
-3.56
-3.47
-3.43
-3.75
-3.52
-3.34
Change in receivables
-0.01
-0.42
0.45
-0.24
0.14
0.11
0
-0.02
0.02
0.01
Change in payables
-0.14
3.58
-2.59
0.7
-1.47
-0.04
-0.51
-0.06
0.32
1.66
Cash from operations
-8.69
-15.4
-22.1
-23.5
-8.25
-5.12
-3.94
-3.09
-1.83
-3.25
Capital expenditures
-0.12
-0.3
-0.01
-0.65
Cash from investing
-0.08
13.5
12.7
9.56
-0.12
0.14
25
-1
Stock issued
0
0
-1.81
0
0.22
0.42
0.05
0.07
25
Cash from financing
-0.03
-0.09
26.9
10.1
0.22
0.42
0.05
3.12
0.07
30
Exchange rate effect
0
0.01
0
-0
-0.02
0
0
-0.01
-0
0.02
Net change in cash
-8.8
-1.96
17.6
-3.82
-8.03
-4.82
-3.74
0.02
23.2
25.8
Free cash flow
-8.81
-15.7
-22.1
-24.1
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $3.20 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-43.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-33.0%
Net income / average total assets.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-6.5%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-5.1%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-7.6%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
17.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
2.5%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-3.2%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
3.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
4.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
2.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.11x
Current assets / current liabilities.
Quick ratio
1.11x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.10x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share
-$0.03
Cash from operations / diluted weighted shares.
Book value per share
$0.67
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
4.77x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
4.77x
Market cap / tangible book value, when positive.
Earnings yield
-9.0%
Net income / market cap (the inverse of P/E).
Was Trilogy Metals Inc. profitable in fiscal 2025?
No. It reported a net loss of $42.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.